Osteoarthritis: Animal data show VEGF blocker inhibits post-traumatic OA

Nature Reviews Rheumatology 10, 638 (2014). doi:10.1038/nrrheum.2014.173 Author: Caroline Barranco Early treatment with the anti-VEGF antibody bevacizumab retards the development of post-traumatic knee osteoarthritis (OA), according to new results published in Arthritis Research & Therapy.Masato Sato and colleagues' study shows that systemic bevacizumab treatment reduces synovitis, osteophyte formation and articular cartilage degradation in

http://feeds.nature.com/~r/nrrheum/rss/current/~3/ZBxJEEj6SB8/nrrheum.2014.173

Source: Nature Reviews Rheumatology - October 7, 2014 Category: Rheumatology Authors: Caroline Barranco Tags: Research Highlight Source Type: research